Tekla Capital Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $700K | Hold |
75,000
| – | – | 0.03% | 134 |
|
|
2023
Q1 | $666K | Sell |
75,000
-25,000
| -25% | -$222K | 0.03% | 141 |
|
|
2022
Q4 | $498K | Hold |
100,000
| – | – | 0.02% | 148 |
|
|
2022
Q3 | $580K | Hold |
100,000
| – | – | 0.02% | 144 |
|
|
2022
Q2 | $553K | Hold |
100,000
| – | – | 0.02% | 148 |
|
|
2022
Q1 | $1.15M | Hold |
100,000
| – | – | 0.04% | 141 |
|
|
2021
Q4 | $1.27M | Buy |
+100,000
| New | +$1.27M | 0.04% | 142 |
|